Transrenal DNA testing: progress and perspectives

References

• Bret L, Lule J, Pourrat JP, Fournie GJ. Extracellular DNA in blood and urine as a potential marker for cytotoxicity and nephrotoxicity in the mouse. Ren. Fail. 12(3), 133–139 (1990).
   PubMedGoogle Scholar
• Virtanen M, Syvanen AC, Oram J, Soderlund H, Ranki M. Cytomegalovirus in urine: detection of viral DNA by sandwich hybridization. Clin. Microbiol. 20(6), 1083–1088 (1984).
   Google Scholar
• Melchers WJ, Schift R, Stolz E, Lindeman J, Quint WG. Human papillomavirus detection in urine samples from male patients by the polymerase chain reaction. J. Clin. Microbiol. 27(8), 1711–1714 (1989).
   PubMedGoogle Scholar
• Malloy DC, Nauman RK, Paxton HJ. Detection of Borrelia burgdorferi using the polymerase chain reaction. Clin. Microbiol. 28(6), 1089–1093 (1990).
   Google Scholar
• Prinz M, Grellner W, Schmitt C. DNA typing of urine samples following several years of storage. Int. J. Legal. Med. 106(2), 75–79 (1993).
   PubMed Web of Science ®Google Scholar
• Yokota M, Tatsumi N, Tsuda I, Takubo T, Hiyoshi M. DNA extraction from human urinary sediment. J. Clin. Lab. Anal. 12(2), 88–91 (1998).
   PubMed Web of Science ®Google Scholar
• Bret L, Hasim M, Lefebvre H, Fournie GJ, Braun JP. Kidney tubule enzymes and extracellular DNA in urine as markers for nephrotoxicity in the guinea-pig. Enzyme Protein 47(1), 27–36 (1993).
   PubMedGoogle Scholar
• Le Lann AD, Bret LC, Delverdier ME, Amardeilh MF, Alary C, Fournie GJ. Urinary DNA as an indicator of nephrotoxicity caused by endotoxin and gentamicin in mice. Toxicology 92(1–3), 1–10 (1994).
   PubMedGoogle Scholar
• Fitzgerald JM, Ramchurren N, Rieger K et al. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. J. Natl Cancer Inst. 87(2), 129–133 (1995).
   PubMed Web of Science ®Google Scholar
• Mao L, Schoenberg MP, Scicchitano M et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science 271(5249), 659–662 (1996).
   PubMed Web of Science ®Google Scholar
• Yamada H, Kakehi Y, Okuno H, Yoshida O. Detection of tumor-derived DNA in exfoliated cells of urine sediments with a novel quantitative PCR method based on allele-specific PCR. Cancer Lett. 126(1), 111–118 (1998).
   PubMedGoogle Scholar
• Cairns P, Esteller M, Herman JG et al. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res. 7(9), 2727–2730 (2001).
   PubMed Web of Science ®Google Scholar
• Goessl C, Muller M, Heicappell R et al. DNA-based detection of prostate cancer in urine after prostatic massage. Urology 58(3), 335–338 (2001).
   PubMed Web of Science ®Google Scholar
• Chan MW, Chan LW, Tang NL et al. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients. Int. J. Cancer. 104(5), 611–616 (2003).
   PubMed Web of Science ®Google Scholar
• Cairns P. Detection of promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Ann. NY Acad. Sci. 1022, 40–43 (2004).
   PubMed Web of Science ®Google Scholar
• Hoque MO, Begum S, Topaloglu O et al. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res. 64(15), 5511–5517 (2004).
   PubMed Web of Science ®Google Scholar
• Chernesky MA, Lee H, Schachter J et al. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J. Infect. Dis. 170(5), 1308–1311 (1994).
   PubMedGoogle Scholar
• Smith KR, Ching S, Lee H et al. Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. Clin. Microbiol. 33(2), 455–457 (1995).
   Google Scholar
• Murdoch DR, Walford EJ, Jennings LC et al. Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia. Clin. Infect. Dis. 23(3), 475–480 (1996).
   PubMed Web of Science ®Google Scholar
• Kafwabulula M, Ahmed K, Nagatake T et al. Evaluation of PCR-based methods for the diagnosis of tuberculosis by identification of mycobacterial DNA in urine samples. Int. J. Tuberc. Lung Dis. 6(8), 732–737 (2002).
   PubMed Web of Science ®Google Scholar
• Hinata N, Shirakawa T, Okada H, Shigemura K, Kamidono S, Gotoh A. Quantitative detection of Escherichia coli from urine of patients with bacteriuria by real-time PCR. Mol. Diagn. 8(3), 179–184 (2004).
   PubMedGoogle Scholar
• Yasuda T, Iida R, Takeshita H et al. A simple method of DNA extraction and STR typing from urine samples using a commercially available DNA/RNA extraction kit. J. Forensic Sci. 48(1), 108–110 (2003).
   PubMed Web of Science ®Google Scholar
• van der Hel OL, van der Luijt RB, Bueno de Mesquita HB et al. Quality and quantity of DNA isolated from frozen urine in population-based research. Anal. Biochem. 304(2), 206–211 (2002).
   PubMed Web of Science ®Google Scholar
• van Duijnhoven FJ, van der Hel OL, van der Luijt RB, Bueno de Mesquita HB, van Noord PA, Peeters PH. Quality of NAT2 genotyping with restriction fragment length polymorphism using DNA isolated from frozen urine. Cancer Epidemiol. Biomarkers Prev. 11(8), 771–776 (2002).
   PubMedGoogle Scholar
• van Noord PA. Banking of urine sediments as DNA source in epidemiologic studies. Epidemiology 14(2), 254 (2003).
   PubMedGoogle Scholar
• Rios M, Cash K, Strupp A, Uehlinger J, Reid M. DNA from urine sediment or buccal cells can be used for blood group molecular genotyping. Immunohematol 15(2), 61–65 (1999).
   PubMedGoogle Scholar
• Botezatu I, Serdyuk O, Potapova G et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin. Chem. 46(8 Pt 1), 1078–1084 (2000).
   PubMed Web of Science ®Google Scholar
• Lichtenstein AV, Melkonyan HS, Tomei LD, Umansky SR. Circulating nucleic acids and apoptosis. Ann. NY Acad. Sci. 945, 239–249 (2001).
   PubMed Web of Science ®Google Scholar
• Massry SG, Glassock RJ. Textbook of Nephrology (Volume 1). Williams & Wilkins, MD, USA, 102–103 (1995).
   Google Scholar
• Lote C. Principles of Renal Physiology. Chapman & Hall, NY, USA, 39 (2000).
   Google Scholar
• Al-Yatama MK, Mustafa AS, Ali S, Abraham S, Khan Z, Khaja N. Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction. Prenat. Diagn. 21(5), 399–402 (2001).
   PubMedGoogle Scholar
• Shi WJ, Sun YH, Cui LJ, Zhang Y, Li SR. Detection of cell-free fetal DNA in the urine of pregnant women by nested polymerase chain reaction. Zhonghua Yi Xue Za Zhi. 83(6), 482–484 (2003).
   PubMedGoogle Scholar
• Koide K, Sekizawa A, Iwasaki M et al. Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women. Prenat. Diagn. 25(7), 604–607 (2005).
   PubMedGoogle Scholar
• Li Y, Zhong XY, Kang A, Troeger C, Holzgreve W, Hahn S. Inability to detect cell free fetal DNA in the urine of normal pregnant women nor in those affected by preeclampsia associated HELLP syndrome. J. Soc. Gynecol. Investig. 10(8), 503–508 (2003).
   PubMedGoogle Scholar
• Zhang J, Tong KL, Li PK et al. Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. Clin. Chem. 45(10), 1741–1746 (1999).
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ohkohchi N, Sakurada M et al. Diagnosis of acute rejection by analysis of urinary DNA of donor origin in renal transplant recipients. Transplant. Proc. 33(1–2), 380–381 (2001).
   PubMedGoogle Scholar
• Su YH, Wang M, Brenner DE et al. Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J. Mol. Diagn. 6(2), 101–107 (2004).
   PubMed Web of Science ®Google Scholar
• Utting M, Werner W, Muller G, Schubert J, Junker K. A possible noninvasive method for the detection of bladder cancer in patients: microsatellite analysis of free DNA in urine and blood. Ann. NY Acad. Sci. 945, 31–35 (2001).
   PubMedGoogle Scholar
• Zancan M, Franceschini R, Mimmo C et al. Free DNA in urine: a new marker for bladder cancer? Preliminary data. Int. J. Biol. Markers 20(2), 134–136 (2005).
   PubMed Web of Science ®Google Scholar
• Stroun M, Maurice P, Vasioukhin V et al. The origin and mechanism of circulating DNA. Ann. NY Acad. Sci. 906, 161–168 (2000).
   PubMed Web of Science ®Google Scholar
• Bischoff FZ, Lewis DE, Simpson JL. Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum. Reprod. Update 11(1), 59–67 (2005).
   PubMed Web of Science ®Google Scholar
• Taback B, Hoon DS. Circulating nucleic acids in plasma and serum: past, present and future. Curr. Opin. Mol. Ther. 6(3), 273–278 (2004).
   PubMedGoogle Scholar
• Wong BC, Lo YM. Cell-free DNA and RNA in plasma as new tools for molecular diagnostics. Expert Rev. Mol. Diagn. 3(6), 785–797 (2003).
   PubMed Web of Science ®Google Scholar
• Wyllie AH, Kerr JFR, Currie AR. The significance of apoptosis. Int. Rev. Cytol. 68, 251–306 (1980).
   PubMedGoogle Scholar
• Umansky SR. The genetic program of cell death. Hypothesis and some applications: transformation, carcinogenesis, aging. J. Theor. Biol. 97, 591–602 (1982).
   PubMed Web of Science ®Google Scholar
• Lockshin RA, Osborne B, Zakeri Z. Cell death in the third millennium. Cell Death Differ. 7(1), 2–7 (2000).
   PubMedGoogle Scholar
• Umansky SR, Tomei LD. Apoptosis in the heart. Adv. Pharmacol. 41, 383–407 (1997).
   PubMedGoogle Scholar
• Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nature Med. 2(9), 1035–1037 (1996).
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61(4), 1659–1665 (2001).
   PubMed Web of Science ®Google Scholar
• Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23(16), 2825–2837 (2004).
   PubMed Web of Science ®Google Scholar
• Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist. Update 4(5), 303–313 (2001).
   PubMed Web of Science ®Google Scholar
• Debrabant A, Lee N, Bertholet S, Duncan R, Nakhasi HL. Programmed cell death in trypanosomatids and other unicellular organisms. Int. J. Parasitol. 33, 257–267 (2003).
   PubMed Web of Science ®Google Scholar
• Lee N, Bertholet S, Debrabant A, Muller J, Duncan R, Nakhasi HL. Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ. 9, 53–64 (2002).
   PubMed Web of Science ®Google Scholar
• Al-Olayan EM, Williams GT, Hurd H. Apoptosis in the malaria protozoan, Plasmodium berghei: a possible mechanism for limiting intensity of infection in the mosquito. Int. J. Parasitol. 32, 1133–1143 (2002).
   PubMedGoogle Scholar
• Gal S, Fidler C, Turner S, Lo YM, Roberts DJ, Wainscoat JS. Detection of Plasmodium falciparum DNA in plasma. Ann. NY Acad. Sci. 945, 234–238 (2001).
   PubMed Web of Science ®Google Scholar
• Dery CV, Toth M, Brown M, Horvath J, Allaire S, Weber JM. The structure of adenovirus chromatin in infected cells. J. Gen. Virol. 66, 2671–2684 (1985).
   PubMedGoogle Scholar
• Hsiao JR, Jin YT, Tsai ST. Detection of cell free Epstein–Barr virus DNA in sera from patients with nasopharyngeal carcinoma. Cancer 94, 723–729 (2002).
   PubMedGoogle Scholar
• Chan KC, Lo YM. Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Semin. Cancer Biol. 12, 489–496 (2002).
   PubMedGoogle Scholar
• Pornthanakasem W, Shotelersuk K, Termrungruanglert W, Voravud N, Niruthisard S, Mutirangura A. Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer 1, 2 (2001).
   PubMedGoogle Scholar
• Chan KC, Zhang J, Chan AT et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res. 63, 2028–2032 (2003).
   PubMed Web of Science ®Google Scholar
• Tenenbaum L, Lehtonen E, Monahan PE. Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr. Gene Ther. 3, 545–565 (2003).
   PubMedGoogle Scholar
• Navarre WW, Zychlinsky A. Pathogen-induced apoptosis of macrophages: a common end for different pathogenic strategies. Cell. Microbiol. 2, 265–273 (2000).
   PubMed Web of Science ®Google Scholar
• Bocchino M, Galati D, Sanduzzi A et al. Role of mycobacteria-induced monocyte/macrophage apoptosis in the pathogenesis of human tuberculosis. Int. J. Tuberc. Lung Dis. 9, 375–383 (2005).
   PubMedGoogle Scholar
• Friedlander AM. DNA release as a direct measure of microbial killing by phagocytes. Infect. Immune. 22, 148–154 (1978).
   PubMed Web of Science ®Google Scholar
• Mancuso M, Filosto M, Stevens JC et al. Mitochondrial myopathy and complex III deficiency in a patient with a new stop-codon mutation (G339X) in the cytochrome b gene. J. Neurol. Sci. 209, 61–63 (2003).
   PubMed Web of Science ®Google Scholar
• Wang M, Block TM, Steel L, Brenner DE, Su YH. Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA. Clin. Chem. 50, 211–213 (2004).
   PubMed Web of Science ®Google Scholar
• Schmidt B, Weickmann S, Witt C, Fleischhacker M. Improved method for isolating cell-free DNA. Clin. Chem. 51(8), 1561–1563 (2005).
   PubMed Web of Science ®Google Scholar
• Murai K, Yamanaka M, Akagi K, Anai M. Purification and properties of deoxyribonuclease II from human urine. J. Biochem. (Tokyo) 87(4), 1097–1103 (1980).
   PubMedGoogle Scholar
• Ito K, Minamiura N, Yamamoto T. Human urine DNase I: immunological identity with human pancreatic DNase I, and enzymic and proteochemical properties of the enzyme. J. Biochem. (Tokyo) 95(5), 1399–1406 (1984).
   PubMedGoogle Scholar
• Duerksen JD, Connor KW. Periodicity and fragment size of DNA from mouse TLT hepatoma chromatin and chromatin fractions using endogenous and exogenous nucleases. Mol. Cell. Biochem. 19(2), 93–112 (1978).
   PubMedGoogle Scholar
• Umansky SR, Korol’ BA, Nelipovich PA. In vivo DNA degradation in thymocytes of γ-irradiated or hydrocortisone-treated rats. Biochim. Biophys. Acta 655(1), 9–17 (1981).
   PubMed Web of Science ®Google Scholar
• Su YH, Wang M, Block TM et al. Transrenal DNA as a diagnostic tool: important technical notes. Ann. NY Acad. Sci. 1022, 81–89 (2004).
   PubMed Web of Science ®Google Scholar
• Hashida S, Hashinaka K, Saitoh A et al. Diagnosis of HIV-1 infection by detection of antibody IgG to HIV-1 in urine with ultrasensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using recombinant proteins as antigens. J. Clin. Lab. Anal. 8(4), 237–246 (1994).
   PubMedGoogle Scholar
• Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin. Chem. 48(3), 421–427 (2002).
   PubMed Web of Science ®Google Scholar
• Hanss B, Leal-Pinto E, Bruggeman LA, Copeland TD, Klotman PE. Identification and characterization of a cell membrane nucleic acid channel. Proc. Natl Acad. Sci. USA 95(4), 1921–1926 (1998).
   PubMed Web of Science ®Google Scholar
• Winters-Hilt S, Akeson M. Nanopore cheminformatics. DNA Cell Biol. 23(10), 675–683 (2004).
   PubMedGoogle Scholar
• Lo YM, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350(9076), 485–487 (1997).
   PubMed Web of Science ®Google Scholar
• Lo YM, Tein MS, Lau TK et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62(4), 768–775 (1998).
   PubMed Web of Science ®Google Scholar
• Angert RM, LeShane ES, Lo YM, Chan LY, Delli-Bovi LC, Bianchi DW. Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 h after collection: analysis of first- and third-trimester samples. Clin. Chem. 49(1), 195–198 (2003).
   PubMed Web of Science ®Google Scholar
• Jin P, Warren ST. Understanding the molecular basis of fragile X syndrome. Hum. Mol. Genet. 9(6), 901–908 (2000).
   PubMed Web of Science ®Google Scholar
• Lo YM, Leung TN, Tein MS et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem. 45(2), 184–188 (1999).
   PubMed Web of Science ®Google Scholar
• Sekizawa A, Farina A, Koide K et al. β-globin DNA in maternal plasma as a molecular marker of pre-eclampsia. Prenat. Diagn. 24(9), 697–700 (2004).
   PubMed Web of Science ®Google Scholar
• Gazzaniga P, Nofroni I, Gandini O et al. Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer. Oncol. Rep. 14(5), 1199–1202 (2005).
   PubMed Web of Science ®Google Scholar
• Steiner G, Schoenberg MP, Linn JF, Mao L, Sidransky D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nature Med. 3(6), 621–624 (1997).
   PubMed Web of Science ®Google Scholar
• Sachs MD, Schlechte H, Lenk VS et al. Genetic analysis of Tp53 from urine sediment as a tool for diagnosing recurrence and residual of bladder carcinoma. Eur. Urol. 38(4), 426–433 (2000).
   PubMedGoogle Scholar
• Lo YM, Chan LY, Chan AT et al. Quantitative and temporal correlation between circulating cell-free Epstein–Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 59(21), 5452–5455 (1999).
   PubMed Web of Science ®Google Scholar
• Tomei LD, Cannas A, Fimia G et al. Detection of cell-free proviral HIV DNA in urine of AIDS patients. Proc. XIX Internatl Congr. Clin. Chem. IFCC/AACC July 24–28 (2005).
   Google Scholar
• Goletti D, Cannas A, Chiaccio T et al. Detection of Mycobacterium tuberculosis transrenal DNA from urine samples of patients with pulmonary TB. Proc. 36th Union World Conf. Lung Health & Centers for Disease Control October, Paris, France (2005).
   Google Scholar
• Marini M, Giangregorio M, Kraskinski JC. Complying with the Occupational Safety and Health Administration’s Bloodborne Pathogens Standard: implementing needleless systems and intravenous safety devices. Pediatr. Emerg. Care 20(3), 209–214 (2004).
   PubMed Web of Science ®Google Scholar
• Lee JM, Botteman MF, Xanthakos N, Nicklasson L. Needlestick injuries in the United States: Epidemiological, economic, and quality of life issues. AAOHN J. 53(3), 117–133 (2005).
   PubMedGoogle Scholar
• Beekman SE, Vaughan TE, McCoy KD et al. Hospital bloodborne pathogens programs: program characteristics and blood and body fluid exposure rates. Infect. Control Hosp. Epidemiol. 22(2), 70–72 (2001).
   PubMedGoogle Scholar